These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 38339026)
1. Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review. Potenza RL; Armida M; Popoli P Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339026 [TBL] [Abstract][Full Text] [Related]
2. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977 [TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494 [TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis. Gold ND; Mallard AJ; Hermann JC; Zeifman RJ; Pagni BA; Bogenschutz MP; Ross S J Palliat Med; 2023 Oct; 26(10):1408-1418. PubMed ID: 37167080 [No Abstract] [Full Text] [Related]
5. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model. Conde B; Winck JC; Azevedo LF Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082 [TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis with upper motor neuron predominance: diagnostic accuracy of qualitative and quantitative susceptibility metrics in the precentral gyrus. Lo Russo F; Contarino VE; Conte G; Morelli C; Trogu F; Casale S; Sbaraini S; Caschera L; Genovese V; Liu C; Cinnante CM; Silani V; Triulzi FM Eur Radiol; 2023 Nov; 33(11):7677-7685. PubMed ID: 37606662 [TBL] [Abstract][Full Text] [Related]
9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis. Fiscon G; Conte F; Amadio S; Volonté C; Paci P Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813 [TBL] [Abstract][Full Text] [Related]
11. Drugs in clinical development for the treatment of amyotrophic lateral sclerosis. Martinez A; Palomo Ruiz MD; Perez DI; Gil C Expert Opin Investig Drugs; 2017 Apr; 26(4):403-414. PubMed ID: 28277881 [TBL] [Abstract][Full Text] [Related]
12. Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. Quinn C; Elman L Continuum (Minneap Minn); 2020 Oct; 26(5):1323-1347. PubMed ID: 33003004 [TBL] [Abstract][Full Text] [Related]
17. Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update. Mohi-Ud-Din R; Mir RH; Shah AJ; Sabreen S; Wani TU; Masoodi MH; Akkol EK; Bhat ZA; Khan H Curr Neuropharmacol; 2022; 20(1):179-193. PubMed ID: 33913406 [TBL] [Abstract][Full Text] [Related]
18. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study. Deeb O; Nabulsi M Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341 [TBL] [Abstract][Full Text] [Related]
19. Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence. Chapman L; Cooper-Knock J; Shaw PJ Brain; 2023 May; 146(5):1745-1757. PubMed ID: 36918362 [TBL] [Abstract][Full Text] [Related]
20. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol. Kalmar B; Lu CH; Greensmith L Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]